Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 313.26B | 315.42B | 299.60B | 275.06B | 253.39B | 283.75B |
Gross Profit | 114.83B | 114.78B | 108.96B | 97.93B | 95.00B | 126.76B |
EBITDA | 29.53B | 34.36B | 41.08B | 33.47B | 30.21B | 31.14B |
Net Income | 13.39B | 12.49B | 17.58B | 13.67B | 13.96B | 8.75B |
Balance Sheet | ||||||
Total Assets | 429.65B | 435.07B | 431.60B | 396.73B | 382.02B | 369.15B |
Cash, Cash Equivalents and Short-Term Investments | 79.64B | 98.48B | 80.76B | 70.75B | 81.01B | 88.42B |
Total Debt | 13.72B | 20.29B | 12.33B | 10.65B | 5.86B | 5.41B |
Total Liabilities | 110.47B | 112.19B | 109.99B | 95.39B | 83.45B | 81.86B |
Stockholders Equity | 289.82B | 292.82B | 292.21B | 272.29B | 268.97B | 258.14B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 13.41B | 12.90B | 4.32B | 2.37B | 12.19B |
Operating Cash Flow | 0.00 | 26.57B | 25.57B | 19.48B | 16.14B | 23.18B |
Investing Cash Flow | 0.00 | -12.28B | -2.30B | -21.47B | -10.40B | -8.56B |
Financing Cash Flow | 0.00 | -9.06B | -7.38B | -12.74B | -10.07B | -6.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | $272.52B | 21.21 | 4.20% | 1.72% | 5.28% | -26.90% | |
65 Neutral | $27.33B | 15.36 | -4.01% | 3.14% | 1.00% | 1.98% | |
€1.80B | 50.90 | 2.04% | 1.91% | ― | ― | ||
72 Outperform | ¥260.29B | 21.27 | 6.84% | 3.47% | -15.46% | ||
63 Neutral | ¥296.27B | 51.71 | 2.69% | 2.58% | -90.84% | ||
61 Neutral | ¥255.59B | 16.23 | 1.98% | 25.63% | -24.35% | ||
46 Neutral | ¥240.18B | 107.71 | 1.86% | 18.99% | -65.82% |